February 2021

Pipeline drugs, expanding pharmacist roles, and a focus on COVID-19 vaccination are trends to watch for in 2021.

This model focuses sharply on orphan diseases to better address the patient experience, outcomes, and requirements of each study.

Research over the past decade has shown that PV can be associated with a reduction in survival compared with age- and gender-matched population controls.

There are specific treatment options patients may qualify for depending on the cytogenetic or molecular abnormality detected.

The CDC recommends that patients with cancer and COVID-19 have a conversation with their health care provider or care team to discuss the individual level of risk based on the patient’s current condition, treatment, and the level of transmission within their community.

This activity is supported by educational grants from Seagen Inc., Daiichi Sankyo, and AstraZeneca.

Directions in Oncology Pharmacy® talks to Gordon Vanscoy, PharmD, MBA, CACP, recently named a national Entrepreneur of the Year for 2020 by Ernst & Young.

“Digital medicine and its regulation are constantly evolving, which is a great thing.”—Betsy Cernero, PharmD

This activity is supported by an educational grant from Incyte Corporation.

This activity is supported by an independent medical education grant from AcelRx Pharmaceuticals, Inc.

In a live virtual symposium presented at the 2020 ASHP Midyear Clinical Meeting and Exhibition, Allison Baxley, PharmD, BCOP, and Laura Alwan, PharmD, BCOP, engaged pharmacists in learning about the role of biomarkers in cervical and endometrial cancers.

Often, patients with cancer face having to quit their jobs, apply for disability payments, and deplete their savings, which can lead to bankruptcy.

Two expert speakers at the 2020 ASHP Midyear Clinical Meeting and Exhibition presented Immune Checkpoint Inhibitors: Resolving Dosing Confusion to Better Care for Patients With Cancer, a virtual symposium.

Statins have become a standard part of treatment for certain patients with cancer to prevent cardiotoxicity and promote antitumor activity.

As a direct result of the global pandemic, the landscape for oncology health care professionals has changed.

Current cancer research focuses heavily on adjunct immunotherapy in combination with traditional chemotherapy.

Presentation provides an overview of recent FDA approvals for therapies utilized in patients with various cancer types.

The classes of approved cell and gene therapies are expected to expand rapidly in the next few years based on projections in the field.

Medication reconciliation is a critical component of the oncology pharmacistʼs duties that has been performed safely over the phone with the patient, caregiver, and pharmacy with the assistance of electronic health records.

Educating patients about cervical cancer and the HPV vaccine can help reduce the number of cases.

Our cover article focuses on notable oncology trends for 2021.